Astrana Health (NASDAQ:ASTH – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $1.12-1.36 for the period, compared to the consensus earnings per share estimate of $1.48. The company issued revenue guidance of $1.75-1.85 billion, compared to the consensus revenue estimate of $1.76 billion.
Analyst Ratings Changes
ASTH has been the subject of a number of recent analyst reports. Robert W. Baird assumed coverage on Astrana Health in a research report on Thursday, May 30th. They set an outperform rating and a $54.00 price objective for the company. Truist Financial raised shares of Astrana Health from a hold rating to a buy rating and boosted their price target for the company from $44.00 to $50.00 in a research note on Thursday, July 11th. Stifel Nicolaus upped their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the stock a buy rating in a report on Thursday, August 1st. Finally, Baird R W upgraded shares of Astrana Health to a strong-buy rating in a report on Thursday, May 30th. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Astrana Health presently has an average rating of Buy and an average price target of $53.50.
Read Our Latest Report on Astrana Health
Astrana Health Stock Down 2.6 %
Astrana Health (NASDAQ:ASTH – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). The business had revenue of $404.36 million for the quarter, compared to analysts’ expectations of $413.84 million. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. Astrana Health’s quarterly revenue was up 19.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.42 earnings per share. As a group, equities analysts anticipate that Astrana Health will post 1.42 earnings per share for the current year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Further Reading
- Five stocks we like better than Astrana Health
- Compound Interest and Why It Matters When Investing
- What Are Bonds? A High-Level Overview
- The 3 Best Retail Stocks to Shop for in August
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.